Banner

Antacids Global Market Report 2022 – Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Formulation Type (Tablet, Liquid, Powder, Others) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : October 2022 | SKU CODE : 7041 | Delivery Time: 2-3 business days | Format :


The antacids market consists of sales of antacids that are used to neutralize stomach acid, and treat acid reflux, heartburn, and indigestion. It includes drug classes such as proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers in the form of either tablet, liquid, or powder. Examples of antacids include Alka Seltzer, Maalox, Mylanta, Rolaids, Tums, and Pepto-Bismol.

The main classes of antacids are proton pump inhibitors, h2 antagonists, acid neutralizers, and pro-motility agents. Proton-pump inhibitors are a type of drug that reduces stomach acid production significantly and for a long time. They accomplish so by blocking the H+/K+ ATPase proton pump in the stomach in an irreversible manner. The different types of formulations include tablet, liquid, powder, and others and are distributed through various channels such as hospital pharmacies, retail pharmacies, and others.

The antacids market research report is one of a series of new reports from The Business Research Company that provides antacids market statistics, including antacids industry global market size, regional shares, competitors with an antacids market share, detailed antacids market segments, market trends, and opportunities, and any further data you may need to thrive in the antacids industry. This antacids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global antacids market grew from $8.58 billion in 2021 to $9.17 billion in 2022 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The antacids market is expected to grow to $10.24 billion in 2026 at a CAGR of 2.8%.

Poor lifestyle choices resulting in a higher prevalence of acidity are an important driver for the growth of the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep, and irregular dietary habits, which result in an increase in the acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffer from gastroesophageal reflux disease. This drives the demand for antacids.

The side effects related to antacids are a major restraint for the antacids market. Some of the common side effects of antacids include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may also cause side effects such as constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. In addition, antacids when consumed with other acidic drugs might lead to absorption of both the drugs resulting in reduced efficiency of both the drugs.

Mouth-melting antacid is an emerging trend in the antacid market. Antacids were available in tablet, liquid, and powder form until now, however, researchers have now come up with mouth-melting antacids which are made up of micro-mouth melting granules that easily melt in the mouth. These granules present in the antacids act in the form of effervescent. An example of a mouth-melting instant relief antacid is Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents present in it with the contemporary mouth-melting technology.

The manufacturers of antacids in the USA need to comply with CFR - Code of Federal Regulations Title 21 laid down by the FDA. According to these regulations, an over-the-counter (OTC) antacid product in a form suitable for oral administration is recognized as safe and effective only if it meets the conditions related to active ingredients established by the regulatory body.

Major players in the antacids market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd and AstraZeneca PLC., Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd, Takeda Pharmaceutical Company Limited, Abbott Laboratories and WellSpring Pharm.

North America was the largest region in the antacids market in 2021. Middle East is expected to be the fastest growing region. The regions covered in the antacids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antacids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global antacids market is segmented -

1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents

2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others

3) By Formulation Type: Tablet, Liquid, Powder, Others

    Table Of Contents

    1. Executive Summary

    2. Antacids Market Characteristics

    3. Antacids Market Trends And Strategies

    4. Antacids Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Antacids Market

    4.2 Ukraine-Russia War Impact On Antacids Market

    4.3 Impact Of High Inflation On Antacids Market

    5. Antacids Market Size And Growth

    5.1. Global Antacids Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Antacids Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Antacids Market Segmentation

    6.1. Global Antacids Market, Segmentation  Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Proton Pump Inhibitors

    H2 Antagonist

    Acid Neutralizers

    Pro-Motility Agents

    6.2. Global Antacids Market, Segmentation  Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

     Hospital Pharmacies

    Retail Pharmacies

    Others

    6.3. Global Antacids Market, Segmentation  By Formulation Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Tablet

    Liquid

    Powder

    Others  

    7. Antacids Market Regional And Country Analysis

    7.1. Global Antacids Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Antacids Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Antacids Market  

    8.1. Asia-Pacific Antacids Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Antacids Market  

    9.1. China Antacids Market Overview  

    9.2. China Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Antacids Market  

    10.1. India Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Antacids Market  

    11.1. Japan Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Antacids Market  

    12.1. Australia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Antacids Market  

    13.1. Indonesia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Antacids Market  

    14.1. South Korea Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Antacids Market  

    15.1. Western Europe Antacids Market Overview

    15.2. Western Europe Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Antacids Market  

    16.1. UK Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Antacids Market  

    17.1. Germany Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Antacids Market  

    18.4. France Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Antacids Market  

    19.1. Eastern Europe Antacids Market Overview

    19.2. Eastern Europe Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Antacids Market  

    20.1. Russia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Antacids Market  

    21.1. North America Antacids Market Overview

    21.2. North America Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Antacids Market  

    22.1. USA Antacids Market Overview

    22.2. USA Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Antacids Market  

    23.1. South America Antacids Market Overview

    23.2. South America Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Antacids Market  

    24.1. Brazil Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Antacids Market  

    25.1. Middle East Antacids Market Overview

    25.2. Middle East Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Antacids Market  

    26.1. Africa Antacids Market Overview

    26.2. Africa Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Antacids Market Competitive Landscape And Company Profiles

    27.1. Antacids Market Competitive Landscape

    27.2. Antacids Market Company Profiles

    27.2.1. GlaxoSmithKline plc

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bayer AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Dr. Reddy's Laboratories Ltd

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. AstraZeneca PLC

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Antacids Pipeline Analysis

    29. Key Mergers And Acquisitions In The Antacids Market

    30. Antacids Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Antacids Market, Segmentation  Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Antacids Market, Segmentation  Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Antacids Market, Segmentation  By Formulation Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Antacids Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Antacids Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: GlaxoSmithKline plc Financial Performance
  • Table 47: Pfizer Inc Financial Performance
  • Table 48: Bayer AG Financial Performance
  • Table 49: Dr. Reddy's Laboratories Ltd Financial Performance
  • Table 50: AstraZeneca PLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Antacids Market, Segmentation  Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Antacids Market, Segmentation  Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Antacids Market, Segmentation  By Formulation Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Antacids Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Antacids Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: GlaxoSmithKline plc Financial Performance
  • Figure 47: Pfizer Inc Financial Performance
  • Figure 48: Bayer AG Financial Performance
  • Figure 49: Dr. Reddy's Laboratories Ltd Financial Performance
  • Figure 50: AstraZeneca PLC Financial Performance
The Aesthetic Medicine Market Share, Market Size, And Growth Rate 2022
The Leukemia Therapeutics Market Share, Market Size, And Growth Rate 2022
How Will The Medical Foods Market Grow In 2022?
How Will The Filgrastim Biosimilar Market Grow In 2022?
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth
The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth
Antiobesity Global Market Report 2022 – By Drug Class (Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs), By Type (Prescription Drugs (Rx), OTC Drugs), By Medication (Monotherapies, Polytherapies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Drug Delivery Devices Global Market Report 2022 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Analgesics Global Market Report 2022 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical), By Drug Type (Prescription Analgesics, OTC Analgesics), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Antidiarrhoeals Global Market Report 2022 – By Drug Class (Mucosal Protectants, Motility Modifying Drugs), By Application (Adults, Childrens), By Type (OTC drugs, Prescription Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Acne Drugs Market 2021 - By Type (Non-Inflammatory Acne Drugs, Inflammatory Acne Drugs), By End-User (Hospitals And Clinics), By Therapeutic Class (Benzoyl Peroxide, Retinoids, Antibiotics, Salicylice) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Antiobesity Drugs Global Market Report 2020 - By Drug Class (Peripherally Acting Anti Obesity Drugs, Centrally Acting Anti Obesity Drugs), By Type (Prescription Drugs (Rx), OTC Drugs), By Medication (Monotherapies, Polytherapies)
View Report